AstraZeneca Says Forxiga Approved In EU For Treatment Of Symptomatic Chronic Heart Failure
Roche Reports Positive Results From Phase 3 COMMODORE 2 Study, Evaluating Efficacy And Safety Of Crovalimab
Sandoz: FDA Accepts BLA For Proposed Biosimilar Denosumab